Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
Linkage studies in bipolar disorder (BPD) suggest that a susceptibility locus exists on chromosome 18p11. The myo-inositol monophosphatase 2 gene (IMPA2) maps to this genomic region. Myo-inositol monophosphatase dephosphorylates inositol monophosphate, regenerating free inositol. Lithium, a common treatment for BPD, has been shown to inhibit IMPA2 activity and decrease levels of inositol. It is hypothesized that lithium conveys its therapeutic effect for BPD patients partially through inositol regulation. Hence, dysfunction of inositol caused by IMPA2 irregularity may contribute to the pathophysiology of BPD. In this study, we hypothesize that genetic variations in the IMPA2 gene contributes to increased susceptibility to BPD. We tested this hypothesis by genotyping 9 SNPs (rs1787984; rs585247; rs3974759; rs650727; rs589247; rs669838; rs636173; rs3786285; rs613993) in BPD patients (n=556) and controls (n=735). Genotype and allele frequencies were compared between groups using Chi square contingency analysis. Linkage disequilibrium (LD) between markers was calculated and estimated haplotype frequencies were compared between groups. Single marker analysis revealed several associations between IMPA2 variations and BPD, which were subsequently rendered non-significant after correction for multiple testing. Although our study did not show strong support for an association between the tested IMPA2 polymorphisms and susceptibility to BPD, additional larger studies are necessary to comprehensively investigate a role of the IMPA2 gene in the pathophysiology of BPD.
Bloch
Paul J
PJ
Psychiatric Pharmacogenetics Laboratory, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Weller
Andrew E
AE
Doyle
Glenn A
GA
Ferraro
Thomas N
TN
Berrettini
Wade H
WH
Hodge
Rachel
R
Lohoff
Falk W
FW
D000328:Adult; D001714:Bipolar Disorder / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics*; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D055106:Genome-Wide Association Study / Q000379:methods; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008297:Male; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
D005819:Genetic Markers; D010744:Phosphoric Monoester Hydrolases; C021822:myo-inositol-1 (or 4)-monophosphatase
J Neural Transm (Vienna). 2008 Sep;115(9):1339-45
18665321
Nat Rev Genet. 2007 Sep;8(9):657-62
17703236
Mol Psychiatry. 2009 Aug;14(8):755-63
19488044
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):868-73
16941653
Eur J Hum Genet. 2004 May;12(5):395-9
14872201
Psychiatr Genet. 1998 Winter;8(4):235-8
9861642
Mol Psychiatry. 2008 Jun;13(6):558-69
18317468
Int J Neuropsychopharmacol. 2009 Feb;12(1):33-43
18771604
Biochem Biophys Res Commun. 2004 Nov 26;324(4):1370-8
15504365
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Am J Epidemiol. 2003 Sep 1;158(5):397-400
12936892
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5918-21
8016089
Mol Psychiatry. 2000 Jul;5(4):389-95
10889549
Am J Med Genet. 1997 May 31;74(3):227-37
9184304
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5604-9
10318931
Mol Psychiatry. 2007 Nov;12(11):1033-41
17440433
Ann Hum Genet. 2001 Mar;65(Pt 2):207-19
11427179
Mol Psychiatry. 1999 Jan;4(1):76-84
10089014
J Biol Chem. 2005 Mar 11;280(10):9106-18
15611057
Mol Psychiatry. 2005 Nov;10(11):1017-25
16044173
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13060-5
8917544
Mol Psychiatry. 2002;7(4):337-9
11986976
Mol Psychiatry. 1997 Sep;2(5):393-7
9322233
Arch Gen Psychiatry. 2004 Mar;61(3):300-8
14993118
Cell. 1989 Nov 3;59(3):411-9
2553271
Mol Psychiatry. 2008 Feb;13(2):197-207
17486107
Psychiatr Genet. 2005 Dec;15(4):255-8
16314755
Int J Methods Psychiatr Res. 2004;13(2):93-121
15297906
Arch Gen Psychiatry. 1994 Nov;51(11):849-59; discussion 863-4
7944874
Am J Hum Genet. 1998 Nov;63(5):1531-40
9867708
Mol Psychiatry. 2005 Oct;10(10):900-19
16027739
J Neural Transm (Vienna). 2001;108(7):849-54
11515750
Nat Genet. 2004 Apr;36(4):388-93
15052270
Am J Med Genet. 1996 Sep 20;67(5):491-4
8886169
Theor Popul Biol. 2001 Nov;60(3):227-37
11855957
Am J Hum Genet. 1995 Dec;57(6):1384-94
8533768
Biol Psychiatry. 2004 Oct 1;56(7):483-9
15450783
Am J Med Genet. 1999 Oct 15;88(5):503-9
10490707
Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):72-8
12815743
Neuropsychopharmacology. 2007 Aug;32(8):1727-37
17251911
Biometrics. 1999 Dec;55(4):997-1004
11315092
Nature. 2007 Jun 7;447(7145):661-78
17554300
Am J Med Genet B Neuropsychiatr Genet. 2010 Apr 5;153B(3):830-6
19859903
Mol Psychiatry. 2004 Jun;9(6):621-9
14699425
Mol Psychiatry. 2002;7(2):189-200
11840312
Psychiatr Genet. 2006 Feb;16(1):3-8
16395123
Mol Psychiatry. 1997 Oct-Nov;2(6):501-4
9399696
Biochem Soc Trans. 2009 Oct;37(Pt 5):1099-103
19754460
Mol Psychiatry. 2000 Mar;5(2):165-71
10822344
Am J Epidemiol. 2002 Mar 1;155(5):478-84
11867360
Am J Hum Genet. 1996 Nov;59(5):983-9
8900224
Am J Hum Genet. 2000 Jun;66(6):1933-44
10801388